| human | Q5 |
| P6178 | Dimensions author ID | 01161613505.45 |
| P496 | ORCID iD | 0000-0002-4899-4644 |
| P3829 | Publons author ID | 2656834 |
| P1053 | ResearcherID | D-4903-2013 |
| P735 | given name | Ana | Q482671 |
| Ana | Q482671 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q46019750 | A gastrin-releasing peptide receptor antagonist stimulates Neuro2a neuroblastoma cell growth: prevention by a histone deacetylase inhibitor. |
| Q39087605 | Anti-EGFR therapy combined with neuromedin B receptor blockade induces the death of DAOY medulloblastoma cells. |
| Q39152725 | Antiproliferative activity of the dimeric phloroglucinol and benzophenone derivatives of Hypericum spp. native to southern Brazil |
| Q48499396 | BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells |
| Q39562114 | BDNF/TrkB content and interaction with gastrin-releasing peptide receptor blockade in colorectal cancer |
| Q48840378 | BDNF/TrkB signaling as an anti-tumor target |
| Q34290956 | BDNF/TrkB signaling protects HT-29 human colon cancer cells from EGFR inhibition. |
| Q37608617 | Cancer stem cells and the biology of brain tumors. |
| Q34456325 | Characterization of ectonucleotidases in human medulloblastoma cell lines: ecto-5'NT/CD73 in metastasis as potential prognostic factor |
| Q37809861 | Current and emerging molecular targets in glioma |
| Q39206931 | Effects of Lonomia obliqua caterpillar venom upon the proliferation and viability of cell lines. |
| Q51006023 | Ewing Sarcoma: influence of TP53 Arg72Pro and MDM2 T309G SNPs. |
| Q60980070 | Ewing's sarcoma: Analysis of single nucleotide polymorphism in the EWS gene |
| Q35673725 | Gastrin-releasing peptide receptor (GRPR) mediates chemotaxis in neutrophils |
| Q39045925 | In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma. |
| Q39030443 | Inhibitory activities of trichostatin a in U87 glioblastoma cells and tumorsphere-derived cells. |
| Q37256742 | Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism. |
| Q40646332 | Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication |
| Q45111437 | Neutrality of miniSTR D22S1045 marker by Ewing's sarcoma phenotype |
| Q38994024 | PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines |
| Q47906749 | Phosphodiesterase-4 inhibition and brain tumor growth |
| Q60980093 | Regulation of E-cadherin expression by growth factor receptors in cancer cells |
| Q43800095 | Sodium butyrate enhances the cytotoxic effect of antineoplastic drugs in human lymphoblastic T-cells. |
| Q39544836 | The histone deacetylase inhibitor sodium butyrate in combination with brain-derived neurotrophic factor reduces the viability of DAOY human medulloblastoma cells. |
| Q48117089 | The histone deacetylase inhibitor sodium butyrate promotes cell death and differentiation and reduces neurosphere formation in human medulloblastoma cells. |
| Q50430194 | The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy |
| Q50661989 | Tryptophan hydroxylase 2 (TPH2) gene polymorphisms and psychiatric comorbidities in temporal lobe epilepsy. |
Search more.